August 3, 2007 – Novation, a healthcare contracting and services company of VHA Inc. and the University HealthSystem Consortium (UHC), awarded ev3 Inc. three, three-year contracts beginning Oct. 1, 2007, offering hospital members access to ev3's portfolio of peripheral vascular and neurovascular products through Novation's peripheral interventional, thrombus management and neuro interventional contracts.
ev3's portfolio, which consists of more than 100 products and 1,000 SKUs, includes stents, embolic protection devices, PTA balloons, thrombectomy systems, guidewires, liquid embolics, embolic coils, snares and infusion catheters/wires.
"ev3's breadth of product line and innovative technology offer incredible value beyond price to our members," said Chris Charland, Novation senior director, cardiology contract services.
For more information: www.novationco.com and www.ev3.net
June 13, 2024 
